Patients with SLE had an increased proportion of double negative CD27-IgD- B cells among peripheral CD19+ B cells (16 ± 5.8%, mean ± SD) compared to healthy individuals (7.8 ± 5.8%, p<0.01) (Fig 1B). Here, CD19 is linked to systemic lupus erythematosus.